Eslicarbazepine Acetate
Eslicarbazepine Acetate is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Eslicarbazepine Acetate; Generic name: ESLICARBAZEPINE ACETATE; Manufacturer: Dr.Reddys Laboratories Inc.
| Brand name | Eslicarbazepine Acetate |
|---|---|
| Generic name | ESLICARBAZEPINE ACETATE |
| Manufacturer | Dr.Reddys Laboratories Inc |
| Used for | 1 INDICATIONS AND USAGE Eslicarbazepine acetate tablets are indicated for the treatment of partial-onset seizures in patients 4 years of age and older. Eslicarbazepine acetate tablets are indicated for the treatment of partial-onset seizures in patients 4 years of age and older. ( 1 ) |
| Dosage | 2 DOSAGE AND ADMINISTRATION • Adult Patients: The recommended initial dosage of eslicarbazepine acetate is 400 mg once daily. For some patients, treatment may be initiated at 800 mg once daily if the need for seizure reduction outweighs an increased risk of adverse reactions. Increase the dose in weekly increments of 400 mg to 600 mg once daily, based on clinical response and tolerability, to a recommended maintenance dosage of 800 mg to 1,600 mg once daily. ( 2.2 ) • Pediatric Patients: The rec |
| Active ingredient(s) | ESLICARBAZEPINE ACETATE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=190fccbc-da3f-b175-ac02-f2c4307a15c3 |